74 related articles for article (PubMed ID: 23844521)
1. [Crucial risk factors for renal function deterioration of HIV-infected patients at the AIDS Clinic in Rambam Hospital].
Shahar E; Mugrabi F; Kedem E; Hassoun G; Pollack S
Harefuah; 2013 Apr; 152(4):207-10, 247-8. PubMed ID: 23844521
[TBL] [Abstract][Full Text] [Related]
2. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L
Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
[TBL] [Abstract][Full Text] [Related]
3. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
De Beaudrap P; Diallo MB; Landman R; Guèye NF; Ndiaye I; Diouf A; Kane CT; Etard JF; Girard PM; Sow PS; Delaporte E;
AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1221-7. PubMed ID: 20854202
[TBL] [Abstract][Full Text] [Related]
4. The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir.
Young J; Wang Q; Fux CA; Bernasconi E; Furrer H; Vernazza P; Calmy A; Cavassini M; Weber R; Battegay M; Bucher HC;
HIV Med; 2014 Sep; 15(8):505-10. PubMed ID: 24641488
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients.
Calza L; Trapani F; Tedeschi S; Piergentili B; Manfredi R; Colangeli V; Viale P
Scand J Infect Dis; 2011 Aug; 43(8):656-60. PubMed ID: 21453205
[TBL] [Abstract][Full Text] [Related]
6. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
Rasch MG; Engsig FN; Feldt-Rasmussen B; Kirk O; Kronborg G; Pedersen C; Gerstoft J; Obel N
Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
[TBL] [Abstract][Full Text] [Related]
7. Renal toxicity of long-term therapy with tenofovir in HIV-infected patients.
Monteagudo-Chu MO; Chang MH; Fung HB; Bräu N
J Pharm Pract; 2012 Oct; 25(5):552-9. PubMed ID: 22551561
[TBL] [Abstract][Full Text] [Related]
8. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
Gish RG; Clark MD; Kane SD; Shaw RE; Mangahas MF; Baqai S
Clin Gastroenterol Hepatol; 2012 Aug; 10(8):941-6; quiz e68. PubMed ID: 22507876
[TBL] [Abstract][Full Text] [Related]
9. Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting.
Manosuthi W; Prasithsirikul W; Tantanathip P; Chimsuntorn S; Nilkamhang S; Sungkanuparph S
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):643-50. PubMed ID: 21706942
[TBL] [Abstract][Full Text] [Related]
10. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL
Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight.
Chaisiri K; Bowonwatanuwong C; Kasettratat N; Kiertiburanakul S
Curr HIV Res; 2010 Oct; 8(7):504-9. PubMed ID: 21073439
[TBL] [Abstract][Full Text] [Related]
12. Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2.
Fafin C; Pugliese P; Durant J; Mondain V; Rahelinirina V; De Salvador F; Ceppi C; Perbost I; Rosenthal E; Roger PM; Cua E; Dellamonica P; Esnault V; Pradier C; Moranne O
Nephron Clin Pract; 2012; 120(4):c205-14. PubMed ID: 23037894
[TBL] [Abstract][Full Text] [Related]
13. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G
AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504
[TBL] [Abstract][Full Text] [Related]
14. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B.
Mauss S; Berger F; Filmann N; Hueppe D; Henke J; Hegener P; Athmann C; Schmutz G; Herrmann E
J Hepatol; 2011 Dec; 55(6):1235-40. PubMed ID: 21703180
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
Kalayjian RC; Lau B; Mechekano RN; Crane HM; Rodriguez B; Salata RA; Krishnasami Z; Willig JH; Martin JN; Moore RD; Eron JJ; Kitahata MM
AIDS; 2012 Sep; 26(15):1907-15. PubMed ID: 22824630
[TBL] [Abstract][Full Text] [Related]
16. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.
Crane HM; Kestenbaum B; Harrington RD; Kitahata MM
AIDS; 2007 Jul; 21(11):1431-9. PubMed ID: 17589189
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir-associated proteinuria.
Kelly MD; Gibson A; Bartlett H; Rowling D; Patten J
AIDS; 2013 Jan; 27(3):479-81. PubMed ID: 22874515
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C and baseline renal function among HIV-infected persons in the SUN Study.
Overton ET; Patel P; Mondy K; Bush T; Conley L; Rhame F; Kojic EM; Hammer J; Henry K; Brooks JT;
AIDS Res Hum Retroviruses; 2012 Feb; 28(2):148-55. PubMed ID: 21480819
[TBL] [Abstract][Full Text] [Related]
19. Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients.
Kim YJ; Cho HC; Sinn DH; Gwak GY; Choi MS; Koh KC; Paik SW; Yoo BC; Lee JH
J Gastroenterol Hepatol; 2012 Feb; 27(2):306-12. PubMed ID: 21777281
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of renal impairment observed in tenofovir-treated patients.
O'Donnell EP; Scarsi KK; Darin KM; Gerzenshtein L; Postelnick MJ; Palella FJ
J Antimicrob Chemother; 2011 May; 66(5):1120-6. PubMed ID: 21393145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
